GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (OTCPK:LPCUF) » Definitions » EV-to-FCF

LPCUF (Lee's Pharmaceutical Holdings) EV-to-FCF : -140.55 (As of Apr. 04, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Lee's Pharmaceutical Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Lee's Pharmaceutical Holdings's Enterprise Value is $94.0 Mil. Lee's Pharmaceutical Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.7 Mil. Therefore, Lee's Pharmaceutical Holdings's EV-to-FCF for today is -140.55.

The historical rank and industry rank for Lee's Pharmaceutical Holdings's EV-to-FCF or its related term are showing as below:

LPCUF' s EV-to-FCF Range Over the Past 10 Years
Min: -145.69   Med: 11.37   Max: 264.86
Current: -145.69

During the past 13 years, the highest EV-to-FCF of Lee's Pharmaceutical Holdings was 264.86. The lowest was -145.69. And the median was 11.37.

LPCUF's EV-to-FCF is ranked worse than
100% of 548 companies
in the Drug Manufacturers industry
Industry Median: 23.575 vs LPCUF: -145.69

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-04), Lee's Pharmaceutical Holdings's stock price is $0.1882. Lee's Pharmaceutical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.021. Therefore, Lee's Pharmaceutical Holdings's PE Ratio (TTM) for today is 8.96.


Lee's Pharmaceutical Holdings EV-to-FCF Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings EV-to-FCF Chart

Lee's Pharmaceutical Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.88 -11.73 12.21 -17.24 -

Lee's Pharmaceutical Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.21 - -17.24 - -

Competitive Comparison of Lee's Pharmaceutical Holdings's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lee's Pharmaceutical Holdings's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Lee's Pharmaceutical Holdings's EV-to-FCF falls into.


;
;

Lee's Pharmaceutical Holdings EV-to-FCF Calculation

Lee's Pharmaceutical Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=94.030/-0.669
=-140.55

Lee's Pharmaceutical Holdings's current Enterprise Value is $94.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lee's Pharmaceutical Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lee's Pharmaceutical Holdings  (OTCPK:LPCUF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Lee's Pharmaceutical Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.1882/0.021
=8.96

Lee's Pharmaceutical Holdings's share price for today is $0.1882.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lee's Pharmaceutical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.021.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Lee's Pharmaceutical Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Lee's Pharmaceutical Holdings Business Description

Traded in Other Exchanges
Address
Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Lee's Pharmaceutical Holdings Headlines

No Headlines